+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin



Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin



Pediatric and Developmental Pathology 5(5): 448-464



Tuberous sclerosis complex (TSC) is a genetically heterogeneous disease caused by mutations of TSC1 or TSC2 genes. It involves multiple organ systems resulting in mild to lethal hamartoma formation due to gene mutation in the germ line and loss of heterozygosity (LOH) in somatic cells. Hamartin (TSC1) and tuberin (TSC2) are expressed broadly. However, little is known about tissue susceptibility to hamartomas when equal or similar amounts of TSC gene expression are present. In this study, we present a 19-week gestational age fetus with pathological features of TSC, which was confirmed by finding LOH of TSC2 in a cardiac rhabdomyoma. Developmental expression of hamartin and tuberin in the TSC fetus, an age-matched non-TSC fetus, and a 26-week gestational age non-TSC fetus were analyzed by immunohistochemistry. We found that in addition to the differential expression of the TSC genes in some normal tissues compared with that in the TSC-affected fetus, the cellular localization and distribution of hamartin and tuberin were dramatically different in different tissues. In general, hamartin and tuberin are mainly expressed in epithelial cells, myocytes, and neural tissues. By comparing the incidence of the hamartomas in early childhood and gene expression in tissues, it appears that tissues with co-expression of hamartin and tuberin are prone to a higher incidence of hamartomas than those expressing only one protein, or two proteins but in different patterns of cellular localization.

(PDF emailed within 0-6 h: $19.90)

Accession: 047848768

Download citation: RISBibTeXText

PMID: 12202993

DOI: 10.1007/s10024-001-0210-3


Related references

Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus. Fetal and Pediatric Pathology 23(4): 241-249, 2005

A case of intractable epilepsy: diagnosis of tuberous sclerosis based on histopathological findings and immunohistochemical expression of hamartin and tuberin. No to Hattatsu. Brain and Development 34(1): 49-54, 2002

Tuberous sclerosis in a 20-week gestation fetus: Immunohistochemical study. Acta Neuropathologica 94(2): 180-186, 1997

Developmental expression of the tuberous sclerosis proteins tuberin and hamartin. Acta Neuropathologica 101(3): 202-210, 2001

Multicompartmental distribution of the tuberous sclerosis gene products, hamartin and tuberin. Archives of Biochemistry & Biophysics 404(2): 210-217, August 15, 2002

Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas. Journal of Cutaneous Pathology 30(3): 174-177, 2003

Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis. Journal of Biological Chemistry 276(24): 21017-21021, 2001

Cellular co-localization of hamartin and tuberin and early hamartoma formation in tuberous sclerosis. Laboratory Investigation 82(1): 314A, 2002

Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis. Acta Neuropathologica 99(5): 503-510, 2000

Definition of domains mediating interaction between hamartin and tuberin and disruption by tuberous sclerosis associated mutations. Journal of Medical Genetics 37(Supplement 1): S23, 2000

Hamartin, the product of the tuberous sclerosis 1 gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Research 58(21): 4766-4770, Nov 1, 1998

Distribution between monomeric and heteromeric forms of tuberin in association with hamartin, two proteins involved in tuberous sclerosis. Journal of Investigative Medicine 48(1): 80A, 2000

Interaction between hamartin and tuberin, the protein products of the TSC1 and TSC2 genes mutated in Tuberous Sclerosis. European Journal of Human Genetics 6(SUPPL 1): 116, 1998

Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues. Acta Neuropathologica 99(3): 223-230, 2000

The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners. Mutation Research 658(3): 234-246, 2008